Global Anthracyclines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anthracyclines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Anthracycline is a type of antibiotic that is extracted from numerous types of Streptomyces bacteria. They are used for the treatment of various types of cancer. It damages the DNA of cancer cells and stop its function. This can be done either by intercalating into the base pairs in the DNA minor grooves or by causing free radical damage of the ribose in the DNA. Daunorubicin, doxorubicin, and epirubicin are some of the top examples of anthracyclines.
Anthracyclines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anthracyclines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Leukemia and Hodgkin Lymphoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anthracyclines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anthracyclines key manufacturers include AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc and Meiji Holdings Co., Ltd, etc. AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc are top 3 players and held % sales share in total in 2022.
Anthracyclines can be divided into Oral and Parenteral, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Anthracyclines is widely used in various fields, such as Leukemia, Hodgkin Lymphoma, Bladder Cancer and Breast Cancer, etc. Leukemia provides greatest supports to the Anthracyclines industry development. In 2022, global % sales of Anthracyclines went into Leukemia filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anthracyclines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc
Meiji Holdings Co., Ltd
MicroBiopharm Japan Co., Ltd
Synbias Pharma
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc
Cadila Pharmaceuticals
Cipla Inc
Segment by Type
Oral
Parenteral
Leukemia
Hodgkin Lymphoma
Bladder Cancer
Breast Cancer
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anthracyclines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anthracyclines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anthracyclines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anthracyclines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anthracyclines introduction, etc. Anthracyclines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anthracyclines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Anthracyclines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anthracyclines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Leukemia and Hodgkin Lymphoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anthracyclines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anthracyclines key manufacturers include AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc and Meiji Holdings Co., Ltd, etc. AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc are top 3 players and held % sales share in total in 2022.
Anthracyclines can be divided into Oral and Parenteral, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Anthracyclines is widely used in various fields, such as Leukemia, Hodgkin Lymphoma, Bladder Cancer and Breast Cancer, etc. Leukemia provides greatest supports to the Anthracyclines industry development. In 2022, global % sales of Anthracyclines went into Leukemia filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anthracyclines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc
Meiji Holdings Co., Ltd
MicroBiopharm Japan Co., Ltd
Synbias Pharma
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc
Cadila Pharmaceuticals
Cipla Inc
Segment by Type
Oral
Parenteral
Segment by Application
Leukemia
Hodgkin Lymphoma
Bladder Cancer
Breast Cancer
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anthracyclines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anthracyclines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anthracyclines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anthracyclines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anthracyclines introduction, etc. Anthracyclines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anthracyclines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.